These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10205795)

  • 41. Hymenolepis microstoma: a change in susceptibility to resistance with increasing age of the parasite.
    Howard RJ
    Parasitology; 1977 Oct; 75(2):241-9. PubMed ID: 927890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and characterization of mouse mast cell proteinase-2 and the differential expression and release of mouse mast cell proteinase-1 and -2 in vivo.
    Pemberton AD; Brown JK; Wright SH; Knight PA; McPhee ML; McEuen AR; Forse PA; Miller HR
    Clin Exp Allergy; 2003 Jul; 33(7):1005-12. PubMed ID: 12859460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STAT-6 is an absolute requirement for murine rejection of Hymenolepis diminuta.
    McKay DM; Khan WI
    J Parasitol; 2003 Feb; 89(1):188-9. PubMed ID: 12659328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional correlations between mucosal mast cell activity and immunity to Trichinella spiralis in high and low responder mice.
    Tuohy M; Lammas DA; Wakelin D; Huntley JF; Newlands GF; Miller HR
    Parasite Immunol; 1990 Nov; 12(6):675-85. PubMed ID: 2084610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hymenolepis nana: immunity against oncosphere challenge in mice previously given viable or non-viable oncospheres of H. nana, H. diminuta, H. microstoma and Taenia taeniaeformis.
    Ito A; Onitake K; Sasaki J; Takami T
    Int J Parasitol; 1991 Apr; 21(2):241-5. PubMed ID: 1869358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mode of action of cyclosporin A against Hymenolepis microstoma (Cestoda): relationship between cyclophilin binding and drug-induced damage.
    McLauchlan PE; Roberts HC; Chappell LH
    Parasitology; 2000 Dec; 121 Pt 6():661-70. PubMed ID: 11155937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific cross-immunity between Hymenolepis nana and H. diminuta: effects of transfer of immunity with homologous and heterologous immune mesenteric lymph node cells in BALB/c mice.
    Palmas C; Ecca AR; Gabriele F
    Parassitologia; 1993 Dec; 35(1-3):73-6. PubMed ID: 8065825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice.
    Ghildyal N; McNeil HP; Stechschulte S; Austen KF; Silberstein D; Gurish MF; Somerville LL; Stevens RL
    J Immunol; 1992 Sep; 149(6):2123-9. PubMed ID: 1517575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible immunological damage to the tegument of Hymenolepis diminuta in mice and rats.
    Befus AD; Threadgold LT
    Parasitology; 1975 Dec; 71(3):525-34. PubMed ID: 1202417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of mast cells in the generation of a T-helper type 2 dominated anti-helminthic immune response.
    Ryan NM; Oghumu S
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30670631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hymenolepis diminuta: immunogenicity of the strobilate worm.
    Elowni EE
    Z Parasitenkd; 1983; 69(4):501-5. PubMed ID: 6624197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporin A: drug treatment in vivo affects the kinetics of [14C]glucose transport in Hymenolepis microstoma in vitro.
    Wastling JM; Chappell LH
    Parasitology; 1994 Feb; 108 ( Pt 2)():223-8. PubMed ID: 8159467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its up-regulation during intestinal nematode infection.
    Wastling JM; Scudamore CL; Thornton EM; Newlands GF; Miller HR
    Immunology; 1997 Feb; 90(2):308-13. PubMed ID: 9135562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Young mice expel the tapeworm Hymenolepis diminuta and are protected from colitis by triggering a memory response with worm antigen.
    Arai T; Lopes F; Shute A; Wang A; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G461-G470. PubMed ID: 29351392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood.
    Ghildyal N; Friend DS; Stevens RL; Austen KF; Huang C; Penrose JF; Sali A; Gurish MF
    J Exp Med; 1996 Sep; 184(3):1061-73. PubMed ID: 9064323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hymenolepsis diminuta: mucosal mastocytosis and intestinal smooth muscle hypertrophy occur in tapeworm-infected rats.
    Dwinell MB; Wise RM; Bass P; Oaks JA
    Exp Parasitol; 1998 May; 89(1):92-102. PubMed ID: 9603494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hymenolepis diminuta and H. microstoma: mouse immunoglobulins binding to the tegumental surface.
    Befus AD
    Exp Parasitol; 1977 Feb; 41(1):242-51. PubMed ID: 320030
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of the expulsion phase of Trichinella spiralis on Hymenolepis diminuta infection in mice.
    Behnke JM; Bland PW; Wakelin D
    Parasitology; 1977 Aug; 75(1):79-88. PubMed ID: 593730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of protective immunity in Hymenolepis nana/mouse model.
    Bortoletti G; Gabriele F; Palmas C
    Parassitologia; 1992 Dec; 34(1-3):17-22. PubMed ID: 1339973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host.
    Persaud R; Wang A; Reardon C; McKay DM
    Int J Parasitol; 2007 Mar; 37(3-4):393-403. PubMed ID: 17092505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.